Resection of hepatocellular carcinoma in patients without cirrhosis

British Journal of Surgery

Volumn 98, Issue 5, 2011, Pages 697-703

  Smoot, R L ^a   Nagorney, D M ^a   Chandan, V S ^a   Que, F G ^a   Schleck, C D ^a   Harmsen, W S ^a   Kendrick, M L ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; EPIDEMIOLOGY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TUMOR; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; REOPERATION; TUMOR RECURRENCE; TUMOR VOLUME;

AGED; CARCINOMA, HEPATOCELLULAR; EPIDEMIOLOGIC METHODS; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; REOPERATION; TUMOR BURDEN;

EID: 79953678123     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7401     Document Type: Article

References (23)

1. Parkin DM, Bray F, Ferlay J, Pisani P,. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153-156. (Pubitemid 32911406)
2. Parkin DM, Bray FI, Devesa SS,. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37 (Suppl 8): S4-S66.
3. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al., Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96. (Pubitemid 351521864)
4. McGlynn KA, Tarone RE, El-Serag HB,. A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev 2006; 15: 1198-1203.
5. Llovet JM, Bruix J,. Prospective validation of the Cancer of the Liver Italian Program (CLIP) score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 2000; 32: 679-680.
6. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, et al. (eds). AJCC Cancer Staging Manual (6th edn). Springer: Chicago, 2002.
7. Dindo D, Demartines N, Clavien PA,. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-213. (Pubitemid 38963009)
8. Chang CH, Chau GY, Lui WY, Tsay SH, King KL, Wu CW,. Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver. Arch Surg 2004; 139: 320-325.
9. Chen MF, Tsai HP, Jeng LB, Lee WC, Yeh CN, Yu MC, et al., Prognostic factors after resection for hepatocellular carcinoma in noncirrhotic livers: univariate and multivariate analysis. World J Surg 2003; 27: 443-447.
10. Dupont-Bierre E, Compagnon P, Raoul JL, Fayet G, de Lajarte-Thirouard AS, Boudjema K,. Resection of hepatocellular carcinoma in noncirrhotic liver: analysis of risk factors for survival. J Am Coll Surg 2005; 201: 663-670. (Pubitemid 41539757)
11. Lang H, Sotiropoulos GC, Brokalaki EI, Schmitz KJ, Bertona C, Meyer G, et al., Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers. J Am Coll Surg 2007; 205: 27-36. (Pubitemid 47016970)
12. Lang H, Sotiropoulos GC, Dömland M, Frühauf NR, Paul A, Hüsing J, et al., Liver resection for hepatocellular carcinoma in non-cirrhotic liver without underlying viral hepatitis. Br J Surg 2005; 92: 198-202. (Pubitemid 40269334)
13. Laurent C, Blanc JF, Nobili S, Sa Cunha A, le Bail B, Bioulac-Sage P, et al., Prognostic factors and longterm survival after hepatic resection for hepatocellular carcinoma originating from noncirrhotic liver. J Am Coll Surg 2005; 201: 656-662. (Pubitemid 41539756)
14. Xu L, Huang L, Li BK, Zhang YQ, Li JQ, Yuan YF,. Clinicopathologic features and long-term outcomes of Chinese patients with hepatocellular carcinoma in non-cirrhotic liver. Dig Surg 2008; 25: 376-382.
15. Verhoef C, de Man RA, Zondervan PE, Eijkemans MJ, Tilanus HW, Ijzermans JN,. Good outcomes after resection of large hepatocellular carcinoma in the non-cirrhotic liver. Dig Surg 2004; 21: 380-386. (Pubitemid 40458693)
16. Capussotti L, Muratore A, Amisano M, Massucco P, Polastri R, Bouzari H,. Liver resection for large-size hepatocellular carcinomas in 47 non-cirrhotic patients - no mortality and long-term survival. Hepatogastroenterology 2006; 53: 768-772. (Pubitemid 44682999)
17. Landers DF, Hill GE, Wong KC, Fox IJ,. Blood transfusion-induced immunomodulation. Anesth Analg 1996; 82: 187-204. (Pubitemid 26017405)
18. Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, Camargo A, et al., Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 2008; 359: 1995-2004.
19. Moradpour D, Blum HE,. Pathogenesis of hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2005; 17: 477-483. (Pubitemid 40592703)
20. Thorgeirsson SS, Grisham JW,. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002; 31: 339-346. (Pubitemid 35154440)
21. Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J, Sa Cunha A, et al., Hepatocellular adenoma subtype classification using molecular markers and immunohisto-chemistry. Hepatology 2007; 46: 740-748. (Pubitemid 47436120)
22. Rebouissou S, Amessou M, Couchy G, Poussin K, Imbeaud S, Pilati C, et al., Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature 2009; 457: 200-204.
23. Strong RW,. Transplantation for liver and biliary cancer. Semin Surg Oncol 2000; 19: 189-199.